Cargando…

Insights into the elimination of vivax malaria in China

BACKGROUND: Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics. The aim of study was to highlight the practices and experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Fang, Zhang, Li, Xia, Zhi-Gui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025774/
https://www.ncbi.nlm.nih.gov/pubmed/36941701
http://dx.doi.org/10.1186/s40249-023-01077-0
_version_ 1784909409605910528
author Huang, Fang
Zhang, Li
Xia, Zhi-Gui
author_facet Huang, Fang
Zhang, Li
Xia, Zhi-Gui
author_sort Huang, Fang
collection PubMed
description BACKGROUND: Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics. The aim of study was to highlight the practices and experience targeting vivax malaria control and elimination in China. MAIN BODY: P. vivax malaria was historically endemic in more than 70% of counties in China, with reported vivax malaria cases as high as 26 million a year. After around 70 years of effort, China was certified as malaria-free in June of 2021. The key insights into China’s vivax malaria control and elimination were offered, including radical cure strategies, comprehensive but adaptive strategies targeting species of Plasmodium and Anopheles, mass drug administration, and case-/focus-centred surveillance and response systems. CONCLUSION: The complete global eradication of P. vivax and eventually malaria will be more difficult, and China’s practices and experience could be a valuable reference in this campaign. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10025774
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100257742023-03-21 Insights into the elimination of vivax malaria in China Huang, Fang Zhang, Li Xia, Zhi-Gui Infect Dis Poverty Commentary BACKGROUND: Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics. The aim of study was to highlight the practices and experience targeting vivax malaria control and elimination in China. MAIN BODY: P. vivax malaria was historically endemic in more than 70% of counties in China, with reported vivax malaria cases as high as 26 million a year. After around 70 years of effort, China was certified as malaria-free in June of 2021. The key insights into China’s vivax malaria control and elimination were offered, including radical cure strategies, comprehensive but adaptive strategies targeting species of Plasmodium and Anopheles, mass drug administration, and case-/focus-centred surveillance and response systems. CONCLUSION: The complete global eradication of P. vivax and eventually malaria will be more difficult, and China’s practices and experience could be a valuable reference in this campaign. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-03-20 /pmc/articles/PMC10025774/ /pubmed/36941701 http://dx.doi.org/10.1186/s40249-023-01077-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Huang, Fang
Zhang, Li
Xia, Zhi-Gui
Insights into the elimination of vivax malaria in China
title Insights into the elimination of vivax malaria in China
title_full Insights into the elimination of vivax malaria in China
title_fullStr Insights into the elimination of vivax malaria in China
title_full_unstemmed Insights into the elimination of vivax malaria in China
title_short Insights into the elimination of vivax malaria in China
title_sort insights into the elimination of vivax malaria in china
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025774/
https://www.ncbi.nlm.nih.gov/pubmed/36941701
http://dx.doi.org/10.1186/s40249-023-01077-0
work_keys_str_mv AT huangfang insightsintotheeliminationofvivaxmalariainchina
AT zhangli insightsintotheeliminationofvivaxmalariainchina
AT xiazhigui insightsintotheeliminationofvivaxmalariainchina